Inventor
ZHAO JIUYANG
CN9 patents
Patents
9 patentsUS10995103B2May 4, 2021
Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
SHENZHEN TARGETRX INC2 citations71
US11319317B2May 3, 2022
(Hetero)arylamide compound for inhibiting protein kinase activity
SHENZHEN TARGETRX INC2 citations70
US11091462B2Aug 17, 2021
(Hetero)arylamide compound for inhibiting protein kinase activity
SHENZHEN TARGETRX INC2 citations70
US10875853B2Dec 29, 2020
(Hetero)arylamide compound for inhibiting protein kinase activity
SHENZHEN TARGETRX INC3 citations70
US11453672B2Sep 27, 2022
Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors
SHENZHEN TARGETRX INC0 citations61
US11389463B2Jul 19, 2022
Antiviral nucleoside reverse transcriptase inhibitor
SHENZHEN TARGETRX INC0 citations61
US11345703B2May 31, 2022
Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound
SHENZHEN TARGETRX INC0 citations61
US11447512B2Sep 20, 2022
Antiviral nucleoside reverse transcriptase inhibitor
SHENZHEN TARGETRX INC0 citations50
US11358973B2Jun 14, 2022
Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity
SHENZHEN TARGETRX INC0 citations49